Overview
The spike protein is a large glycoprotein that projects from the surface of coronaviruses, forming the crown-like spikes that give this family of viruses its name and serving as the principal molecular machinery for entry into host cells. In SARS-CoV-2, the virus responsible for COVID-19, the spike protein binds to a receptor on the host cell surface and mediates fusion of the viral and cellular membranes, enabling infection. Because it is exposed on the viral exterior and essential for entry, the spike protein is the primary target of neutralizing antibodies and a focus of vaccine design, and mutations within it underlie many viral variants. Research in this journal addresses the spike protein and the broader biology of coronaviruses. Studies examine how the SARS-CoV-2 spike protein influences interferon and cytokine gene expression, the molecular evolution of SARS-CoV-2 and analyses based on spike glycoprotein gene sequences, narrative reviews of the novel coronavirus, and the origins and treatment of the virus. Additional work covers cell-based therapies for COVID-19, immune responses following vaccination, neutralizing antibodies in convalescent plasma, and dietary approaches involving mannose-binding lectins. Key aspects of the field include receptor binding and membrane fusion, the spike protein as a vaccine and antibody target, viral evolution and variants, and the immune response to coronavirus infection.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
SARS-Corona Virus-2 Origin and Treatment, From Coffee to Coffee: A Double-Edged Sword
Cell Therapy as an Alternative approach for COVID-19 Infection Consequences: A Non-Systematic Review
Pyrexia And Liver Injury After A Second SARS-CoV-2 Vaccination: Macrophage Activation Manifested In Liver
Molecular Evolution of the Novel Coronavirus SARS-CoV-2
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
Use of the Remaining Sample from the Panbio COVID-19 Antigen Rapid Test Device for the Molecular Screening of the SARS-CoV-2 Variant of Concern B.1.1.7
Anti-COVID19 Vaccine among Workers at the Local Health Authority of Rieti (Italy). Study on the Vaccine Efficacy and Seroprevalence Post-Vaccination
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
How this research is being cited
The 12 articles above have been cited 21 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
R. Paulino-Ramírez et al. · 2023 · International Journal of Environmental Research and Public Health
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · International Journal of Environmental Research and Public Health
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2022 · Biomedicine & Pharmacotherapy
-
2021 ·
A sample of recent works citing this journal's research on Spike Protein, linking to each citing work.